Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth
Haoxi Health Technology (HAO), an online marketing solution provider in Beijing, China, has announced preliminary unaudited financial results for FY24 ended June 30, 2024. The company projects 72% revenue growth to approximately $48.52 million, up from $28.23 million in FY23. Gross profit is expected to increase by 33.4% to $2.75 million, while net income is projected to rise 33.2% to $1.29 million.
HAO attributes this growth to its strategic development in online advertising solutions, particularly through short video formats and news feed ads. The company's proprietary data analysis software, Bidding Compass, has reportedly optimized ad placements, driving revenue and profit growth. Total assets increased to $15.51 million from $4.46 million at the end of FY23, reflecting operational scale and capital utilization post-IPO in January 2024.
Haoxi Health Technology (HAO), un fornitore di soluzioni di marketing online con sede a Pechino, Cina, ha annunciato i risultati finanziari preliminari non revisionati per l'anno fiscale 2024 conclusosi il 30 giugno 2024. L'azienda prevede una crescita del fatturato del 72% fino a circa 48,52 milioni di dollari, rispetto ai 28,23 milioni di dollari dell'anno fiscale 2023. Si prevede che il profitto lordo aumenterà del 33,4% a 2,75 milioni di dollari, mentre il reddito netto dovrebbe salire del 33,2% a 1,29 milioni di dollari.
HAO attribuisce questa crescita allo sviluppo strategico delle soluzioni pubblicitarie online, in particolare attraverso formati video brevi e annunci nel feed di notizie. Il software proprietario di analisi dei dati dell'azienda, Bidding Compass, ha ottimizzato i posizionamenti pubblicitari, contribuendo alla crescita del fatturato e del profitto. Il totale degli attivi è aumentato a 15,51 milioni di dollari rispetto ai 4,46 milioni di dollari alla fine dell'anno fiscale 2023, riflettendo la scala operativa e l'utilizzo del capitale dopo l'IPO di gennaio 2024.
Haoxi Health Technology (HAO), un proveedor de soluciones de marketing en línea en Pekín, China, ha anunciado los resultados financieros preliminares no auditados para el año fiscal 2024 que finalizó el 30 de junio de 2024. La empresa proyecta un crecimiento de ingresos del 72% a aproximadamente 48,52 millones de dólares, frente a los 28,23 millones de dólares en el año fiscal 2023. Se espera que el beneficio bruto aumente un 33,4% a 2,75 millones de dólares, mientras que el ingreso neto se proyecta que aumente un 33,2% a 1,29 millones de dólares.
HAO atribuye este crecimiento a su desarrollo estratégico en soluciones publicitarias en línea, especialmente a través de formatos de video corto y anuncios en el feed de noticias. El software de análisis de datos de propiedad de la empresa, Bidding Compass, ha optimizado la colocación de anuncios, impulsando el crecimiento de ingresos y beneficios. Los activos totales aumentaron a 15,51 millones de dólares desde 4,46 millones de dólares al final del año fiscal 2023, reflejando la escala operativa y la utilización de capital tras la OPI en enero de 2024.
하오시 헬스 테크놀로지(HAO)는 중국 베이징에 위치한 온라인 마케팅 솔루션 제공업체로서 2024 회계연도 제무재무보고서를 2024년 6월 30일 종료 기준으로 예비 감사보고 방식으로 발표했습니다. 회사는 72%의 수익 성장을 예상하며 약 4852만 달러에 이를 것으로 보이며, 이는 2023 회계연도 2823만 달러에서 증가한 수치입니다. 총 이익은 33.4% 증가하여 275만 달러에 이를 것으로 예상되고, 순이익은 33.2% 증가하여 129만 달러에 이를 것으로 예상됩니다.
HAO는 짧은 영상 포맷 및 뉴스 피드 광고를 통한 온라인 광고 솔루션의 전략적 개발 덕분에 이 같은 성장을 이룩했다고 언급했습니다. 회사의 독자적인 데이터 분석 소프트웨어인 Bidding Compass는 광고 투자를 최적화하며 수익 및 이익 성장을 이끌어냈습니다. 총 자산은 2023 회계연도 종료 시 446만 달러에서 1551만 달러로 증가하였으며, 이는 2024년 1월 IPO 이후 운영 규모와 자본 활용을 반영합니다.
Haoxi Health Technology (HAO), un fournisseur de solutions de marketing en ligne basé à Pékin, en Chine, a annoncé les résultats financiers préliminaires non audités pour l'exercice fiscal 2024 se terminant le 30 juin 2024. L'entreprise projette une croissance du chiffre d'affaires de 72% pour atteindre environ 48,52 millions de dollars, contre 28,23 millions de dollars au cours de l'exercice fiscal 2023. Le bénéfice brut devrait augmenter de 33,4% pour atteindre 2,75 millions de dollars, tandis que le bénéfice net est prévu à la hausse de 33,2% pour atteindre 1,29 million de dollars.
HAO attribue cette croissance à son développement stratégique dans les solutions de publicité en ligne, notamment par le biais de formats vidéo courts et d'annonces dans les flux d'actualités. Le logiciel d'analyse de données propriétaire de l'entreprise, Bidding Compass, aurait optimisé le placement des annonces, entraînant une croissance du chiffre d'affaires et des bénéfices. Le total des actifs a augmenté à 15,51 millions de dollars contre 4,46 millions de dollars à la fin de l'exercice fiscal 2023, reflétant l'échelle opérationnelle et l'utilisation du capital après l'introduction en bourse de janvier 2024.
Die Haoxi Health Technology (HAO), ein Anbieter von Online-Marketinglösungen aus Peking, China, hat die vorläufigen, ungeprüften Finanzzahlen für das Geschäftsjahr 2024 zum 30. Juni 2024 veröffentlicht. Das Unternehmen prognostiziert ein Umsatzwachstum von 72% auf etwa 48,52 Millionen US-Dollar, gegenüber 28,23 Millionen US-Dollar im Geschäftsjahr 2023. Der Bruttogewinn wird voraussichtlich um 33,4% auf 2,75 Millionen US-Dollar steigen, während der Nettoertrag um 33,2% auf 1,29 Millionen US-Dollar zunehmen soll.
HAO führt dieses Wachstum auf die strategische Entwicklung von Online-Werbelösungen zurück, insbesondere durch kurze Videoformate und Anzeigen im Nachrichtenticker. Die firmeneigene Datenanalyse-Software Bidding Compass hat offenbar die Anzeigenschaltung optimiert und so Umsatz- und Gewinnwachstum vorangetrieben. Die Gesamtsumme der Vermögenswerte stieg auf 15,51 Millionen US-Dollar von 4,46 Millionen US-Dollar am Ende des Geschäftsjahres 2023, was auf eine operative Skalierung und Kapitalnutzung nach dem IPO im Januar 2024 hinweist.
- Projected 72% year-over-year revenue growth to $48.52 million for FY24
- 33.4% increase in gross profit to $2.75 million for FY24
- 33.2% rise in net income to $1.29 million for FY24
- Total assets grew from $4.46 million to $15.51 million
- Successful implementation of proprietary data analysis software, Bidding Compass
- None.
BEIJING, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced preliminary unaudited financial results for the fiscal year ended June 30, 2024 (“FY24”).
HAO projects revenue growth during FY24, which it attributes to the Company’s strategic development in online advertising solutions, particularly through short video formats and news feed ads. The Company’s proprietary data analysis software, Bidding Compass, enables it to optimize ad placements, which it believes has driven growth in both revenue and profit for FY24.
Key financial highlights (projected preliminary, unaudited results) are provided as below:
- Revenue: Approximately
$48.52 million for FY24, reflecting a72% increase compared to$28.23 million in the fiscal year ended June 30, 2023 (“FY23”). - Gross Profit: Approximately
$2.75 million for FY24, reflecting a33.4% increase from$2.06 million in FY23. - Net Income: Approximately
$1.29 million for FY24, reflecting a33.2% increase from$0.97 million in FY23. - Total Assets: As of June 30, 2024, the Company’s total assets increased to approximately
$15.51 million , from$4.46 million at the end of FY23, reflecting HAO’s operational scale and capital utilization after its initial public offering (“IPO”).
Since its IPO in January 2024, HAO has experienced consistent growth in its core business, benefiting from the demand for targeted healthcare advertising in China. The Company's relationships with major media platforms, combined with its expertise in planning, placing, and optimizing short video ads, has reinforced its goal to be a leading player in the digital healthcare advertising market.
“We believe that our preliminary FY24 results reflect the strength of our business model and our team’s ability to navigate through a rapidly evolving online advertising landscape,” said Mr. Zhen Fan, CEO of the Company. “Our dedicated team, coupled with our focus on the healthcare sector, has enabled us to consistently deliver value to our clients. We look forward to maintaining this momentum as we continue to expand our partnerships and enhance our service offerings.”
As the healthcare sector continues to expand in China, HAO remains committed to capitalizing on these opportunities. With its experience in ad placement strategies and its established partnerships with online advertising platforms in China, the Company aims to further strengthen its foothold in the market.
Note About Preliminary Results
The financial results presented in this release are preliminary and may change. This preliminary financial information includes calculations or figures that have been prepared internally by management. The Company's independent registered public accounting firm has not finished its audit of, and does not express an opinion with respect to, these data. There can be no assurance that the Company’s actual results for the period presented herein will not differ from the preliminary financial results presented herein, and such changes could be material. These preliminary financial results should not be viewed as a substitute for full financial statements prepared in accordance with U.S. GAAP and are not necessarily indicative of the results to be achieved for any future periods. This preliminary financial information could be impacted by the effects of the Company’s financial closing procedures, final adjustments, and other developments, including the ongoing audit of the Company’s consolidated financial statements.
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients. The Company’s growth is driven by the rise of news feed ads and the rapid development of the healthcare sector. The Company offers one-stop online marketing solutions, especially in online short video marketing, helping advertisers acquire and retain customers on popular platforms in China, such as Toutiao, Douyin, WeChat, and Sina Weibo. It is dedicated to reducing costs, increasing efficiency, and providing easy online marketing solutions to advertisers. For more information, please visit: http://ir.haoximedia.com.
Forward-Looking Statement
This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors particular to our industry discussed in the “Risk Factors” section of the registration statement filed with the U.S. Securities and Exchange Commission (the “SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company has no obligation, and undertakes no obligation, to publicly update, revise or correct these forward-looking statements after the date hereof, or after the respective dates on which any such statements otherwise are made.
For more information, please contact:
Investor Relations
WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email: services@wealthfsllc.com
Phone: +86 13811768599
+1 628 283 9214
FAQ
What is HAO's projected revenue growth for FY24?
How much did HAO's net income increase in FY24?
What factors contributed to HAO's growth in FY24?
When did HAO have its IPO and how has it affected the company?
